@article{TGH3640,
author = {Fahmi Mghirbi and Mouna Ayadi and Wafa Karray and Yosra Yahyaoui and Khedija Meddeb and Amina Mokrani and Henda Raies and Nesrine Chraeit and Amel Mezlini},
title = {Squamous cell carcinoma of the gallbladder},
journal = {Translational Gastroenterology and Hepatology},
volume = {1},
number = {8},
year = {2016},
keywords = {},
abstract = {Gallbladder cancer is the most common malignant tumor of the biliary tract. The majority of cases are adenocarcinoma (AC). Pure squamous cell carcinoma (SCC) of gallbladder accounts only 3% of the malignant neoplasm of this organ. Many patients are at advanced stage when diagnosed and have bad therapeutic efficacy. At present, radical surgery is the only chance to gain long-term survival for patients with early-stage gallbladder cancers. Recent reports have shown a benefit of adjuvant chemoradiation in this type of tumor. At present, no therapy is defined for unresectable cancer of the gallbladder, especially for SCC.},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/3640}
}